A Study to Evaluate Safety and Feasibility of Robotic Liver Resection

Status

Recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06353672

Enrollment

1000

Registered

2024-04-09

Start date

2020-12-01

Completion date

2026-12-31

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Diseases, Surgery

Keywords

Robotic liver resection

Brief summary

The robotic surgery system, the most advanced technology in minimally invasive surgery, overcame some shortcomings of laparoscopic surgery and improved the flexibility and precision of liver resection. Several studies have demonstrated that the robotic system was safe and feasible in liver surgery and might be advantageous in complex hepatic vein and hilar dissection, operative bleeding control, and biliary reconstruction. Previous comparative studies found limited evidence for significantly improved outcomes in robotic liver resection (RLR) over laparoscopic liver resection (LLR) or open liver resection (OLR), considering the various degrees of difficulty in liver surgeries. This study aimed to evaluate safety and feasibility of robotic liver resection, by comparing it with LLR or OLR, and gain veritable and relevant data on the benefits of RLR.

Interventions

DEVICERobotic liver resection

Liver resection using Da Vinci robotic system

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* The patients were diagnosed with a liver tumor. * The patients underwent robotic liver resection.

Exclusion criteria

* The patients underwent simultaneous malignancy resection of the colorectum or other organs (except gallbladder).

Design outcomes

Primary

Measure	Time frame	Description
Postoperative complications	with in 90 days after surgery	The grades of postoperative complications were recorded following the Clavien-Dindo classification. Partial hepatic dysfunction or hepatic failure, biliary fistula, postoperative hemorrhage, pleural effusion, venous thrombosis, and surgical site infections were recorded.
Postoperative hospital stay	with in 90 days after surgery	The days of hospital stay after operation
Postoperative unplanned reoperation	with in 90 days after surgery	The unplanned reoperation due to postoperative complications
Unplanned readmission	with in 90 days after surgery	The unplanned readmission after discharge due to postoperative complications

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026